期刊文献+

奥氮平治疗抑郁症的临床治疗体会

Olanzapine Treatment Experience Clinical Depression
下载PDF
导出
摘要 目的探讨奥氮平在抑郁症临床治疗中的应用价值。方法选取2009年9月—2012年5月来该院接受抑郁症治疗的患者100例,其中50例患者采用单纯安非他酮进行治疗,作为对照组,剩下的50例患者在对照组患者治疗的基础上,采用奥氮平进行联合治疗,作为观察组,分别以两组患者治疗前及治疗后第1周、第4周及第8周后的焦虑度、抑郁度、自杀倾向及治疗后临床疗效和治疗过程中不良反应作为临床观察指标,并使用SPSS13.0软件包进行统计学分析。结果观察组患者治疗后的焦虑度、抑郁度、自杀倾向及临床疗效均明显优于对照组患者,(P<0.05或P<0.01);两组患者治疗过程中不良反应差异无统计学意义。结论在安非他酮传统治疗的基础上使用奥氮平进行辅助治疗,可有效的改善抑郁症患者的焦虑、抑郁等不良情绪,并降低患者的自杀倾向,且无明显不良反应,用药安全可靠,具有临床应用价值。 Objective To investigate the effects of olanzapin in the treatment of drpression. Methods Select 100 patients who came to our hospital for depression treatment from September 2009 to May 2012. The 50 patients who only received bupropion for treat- ment as the control group, and the other 50 patients who received bupropion combined olanzapin for treatment as the observation group. Used the anxiety,depression,suicidal tendencies, clinical effecy and the adverse reactions as the clinical index, and used the SPSS 13.0 statistical sofeware for statistical analysis. Results The anxiety,depression,suicidal tendencies, clinical effecy of the ob- servation group was significantly better than the control group, P〈0.05 or P〈0.01;there was no significant drfference in the adverse reactions of two groups,P〉0.05. Conclusion The bupropion combined olanzapin can effectively improve the anxiety,depression of the depression patients,and it also can reduce the suicidal tendencies, which worth for clinical application.
作者 朱列和
出处 《中外医疗》 2013年第20期135-136,共2页 China & Foreign Medical Treatment
关键词 奥氮平 抑郁症 焦虑 自杀倾向 Olanzapin Depression Anxiety Suicidal tendencies
  • 相关文献

参考文献4

二级参考文献17

  • 1陈静,陆峥.非典型抗精神病药治疗难治性抑郁症[J].上海精神医学,2004,16(5):301-303. 被引量:50
  • 2王骞,李胜书,王克.奥氮平辅助治疗难治性抑郁症的观察[J].山东精神医学,2005,18(1):48-49. 被引量:19
  • 3方建忠,梅其一,杨小男.非典型抗精神病药对难治性抑郁症的治疗作用[J].临床精神医学杂志,2007,17(1):36-37. 被引量:60
  • 4Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine - fluoxetine combination in the treatment of bipolar 1 depression [ J ]. Archives of General Psychiatry,2003,60 : 1079-1088.
  • 5Moffitt TE, Harrington H, Caspi A, et al. Depression and general anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry, 2007,64:651-660.
  • 6Aina Y, Susman JL. Understanding comorbidity with depression and anxiety disorders. JAOA,2006,106 ( Supp 12) :9-14.
  • 7Strakowski SM, DelBello MP, Adler CM, et al. Atypical antipsychotics in the treatment of bipolar disorder. Expert Opin Pharmacother, 2003,4:751-760.
  • 8Strakowski S M, DelBello M P, Adler C M, et al. Atypical antipsy chotics in the treatment of bipolar disorder[J]. Expert Opin Pharma- eother, 2003,4 :751-760.
  • 9Tohen M,Vieta E,Calabrese J,et al. Efficacy of olanzapine and olan zapine--fluoxetine combination in the treatment of bipolar 1 depres- sion[J]. Archives of General Psychiatry, 2003,60 : 1079-1088.
  • 10Boku S,Inoue T,Honma H,et al.Olanzapine augmentation of milnacipran for stage 2 treatment-resistant major depression:an open study[J].HumPsychopharmacol Clin Exper,2011,4(26):237-241.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部